MLAB
Mesa Laboratories, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website mesalabs.com
- Employees(FY) 698
- ISIN US59064R1095
Performance
-12.29%
1W
-27.46%
1M
-24.55%
3M
-19.1%
6M
-5.49%
YTD
+11.05%
1Y
Profile
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Technical Analysis of MLAB 2024-11-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-12 19:00
MLAB: Lowering target price to $101.00(Argus Research)
- 2024-11-09 07:22
- 2024-11-07 09:20
- 2024-11-07 08:00
Mesa Labs Announces Second Quarter Results(GlobeNewswire)
- 2024-11-06 19:27
Mesa Labs: Fiscal Q2 Earnings Snapshot(Yahoo Finance)
- 2024-11-06 19:00
Mesa Labs Announces Second Quarter Results(Globenewswire)
- 2024-11-05 19:00
MLAB: Raising target price to $103.00(Argus Research)
- 2024-10-15 17:02
- 2024-10-11 10:56
- 2024-10-08 20:00
MLAB: Lowering target price to $103.00(Argus Research)
- 2024-10-02 14:00
MESA LABS DECLARES QUARTERLY DIVIDEND(GlobeNewswire)
- 2024-10-02 02:00
MESA LABS DECLARES QUARTERLY DIVIDEND(Globenewswire)
- 2024-09-14 10:38
Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 30% Discount?(Simply Wall St.)
- 2024-09-04 09:15
- 2024-08-27 20:00
MLAB: Rating decreased to a SELL(Argus Research)
- 2024-08-26 12:20
- 2024-08-26 12:00
- 2024-08-20 20:00
MLAB: Raising target price to $135.00(Argus Research)
- 2024-08-16 07:51
- 2024-08-05 08:15
Mesa Labs: Fiscal Q1 Earnings Snapshot(Associated Press Finance)
- 2024-08-05 08:00
Mesa Labs Announces First Quarter Results(GlobeNewswire)
- 2024-08-04 20:00
Mesa Labs Announces First Quarter Results(Globenewswire)
- 2024-07-30 21:14
- 2024-07-29 08:20
- 2024-07-23 20:00
MLAB: What does Argus have to say about MLAB?(Argus Research)
- 2024-07-16 20:00
MLAB: Raising target price to $119.00(Argus Research)
- 2024-07-09 20:00
MLAB: Raising target price to $97.00(Argus Research)
- 2024-07-08 14:00
MESA LABS DECLARES QUARTERLY DIVIDEND(GlobeNewswire)
- 2024-07-08 02:00
MESA LABS DECLARES QUARTERLY DIVIDEND(Globenewswire)
- 2024-06-07 06:48
Page 1 of 6
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.